Olivier Bohuon

Senior Advisor
University of Paris XI
Ecole des Hautes Etudes Commerciales

Olivier Bohuon joined EW Healthcare as Senior Advisor in 2018, and serves as the Chairman of the Board of Directors for growth equity portfolio company Laboratoires Majorelle.  He has extensive international healthcare leadership experience with a number of the most successful pharmaceutical and medical device companies in Europe and the United States.  He brings deep knowledge of pharmaceuticals and healthcare in today’s global environment as well as executive and board leadership in the medical technology industry. 

Mr. Bohuon retired recently as CEO of Smith & Nephew (NYSE:  SNN), a leading global medical device company headquartered in London and part of the FTSE 100 Index.  During his tenure at SNN, he led the restructuring of the company, significantly strengthening the company’s foundations.  SNN underwent important and necessary changes, and SNN’s share price nearly doubled under his stewardship.  Mr. Bohuon is well-known to EW Healthcare Partners as a result of our portfolio company, Bioventus, which was spun out of SNN, with SNN retaining a 49% stake.

Before joining SNN, he was the CEO of the Pierre Fabre Group, a private multinational pharmaceutical company headquartered in France. 

Prior to Pierre Fabre, he had a successful career spanning ten years with Abbott Laboratories as Executive Vice-President of the Abbott Corporation and President of its pharmaceutical division.  During his long career with Abbott, Mr. Bohuon also served as the group’s President for European operations as well as President of Abbott International.

Previously, he held commercial leadership positions at GlaxoSmithKline as Senior Vice President and Director for European Commercial Operations. 

Today Mr. Bohuon is a senior independent director at Shire plc, one of the leading global specialty pharmaceutical companies with a $40B market cap where he is also a member of the Science and Technology Committee.  He serves as Vice Chairman of LEO Pharma’s Board of Directors, and is a Board member of Smiths Group plc and a supervisory Board member of Virbac Group SA.  Olivier is also a Member of the French National Academy of Pharmacy and a Member of the French Technology Academy. 

Originally from Paris, France he received his Doctorate in Pharmacy in 1983 from the University of Paris XI, and his Master’s degree in Business Administration from École des Hautes Études Commerciales (HEC) in Paris.  He was awarded Knight of the Legion d’Honneur, the highest French order of merit for military and civil merits, an order originally established in 1802 by Napoléon Bonaparte.